LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Article ; Online: Exome sequencing in 16 patients with pituitary stalk interruption syndrome: A monocentric study.

    Brauner, Raja / Bignon-Topalovic, Joelle / Bashamboo, Anu / McElreavey, Ken

    PloS one

    2023  Volume 18, Issue 12, Page(s) e0292664

    Abstract: Pituitary stalk interruption syndrome (PSIS) is a rare disorder characterized by an absent or ectopic posterior pituitary, absent or interrupted pituitary stalk and anterior pituitary hypoplasia on magnetic resonance imaging (MRI), as well in some cases ... ...

    Abstract Pituitary stalk interruption syndrome (PSIS) is a rare disorder characterized by an absent or ectopic posterior pituitary, absent or interrupted pituitary stalk and anterior pituitary hypoplasia on magnetic resonance imaging (MRI), as well in some cases a range of heterogeneous somatic anomalies. The triad can be incomplete. Here, we performed exome sequencing on 16 sporadic patients, aged 0.4 to 13.7 years diagnosed with isolated or complex PSIS. Growth hormone deficiency was isolated in 10 cases, or associated with thyrotropin deficiency in 6 others (isolated (2 cases), associated with adrenocorticotropin deficiency (1 case), gonadotropins deficiency (1 case), or multiple deficiencies (2 cases)). Additional phenotypic anomalies were present in six cases (37.5%) including four with ophthalmic disorders. In 13 patients variants were identified that may contribute to the phenotype. However, only a single individual carried a variant classified as pathogenic. This child presented with the typical clinical presentation of Okur-Chung neurodevelopmental syndrome due to a CSNK2A1 missense variant. We also identified variants in the holoprosencephaly associated genes GLI2 and PTCH1. A likely pathogenic novel splice site variant in the GLI2 gene was observed in a child with PSIS and megacisterna magna. In the remaining 11 cases 26 variants in genes associated with pituitary development or function were identified and were classified of unknown significance. Compared with syndromic forms the diagnostic yield in the isolated forms of PSIS is low. Although we identified rare or novel missense variants in several hypogonadotropic hypogonadism genes (e.g. FGF17, HS6ST1, KISS1R, CHD7, IL17RD) definitively linking them to the PSIS phenotype is premature. A major challenge remains to identify pathogenic variants in cases with isolated PSIS.
    MeSH term(s) Child ; Humans ; Exome Sequencing ; Pituitary Diseases/diagnosis ; Pituitary Gland/diagnostic imaging ; Pituitary Gland/pathology ; Hypopituitarism/genetics ; Mutation, Missense
    Language English
    Publishing date 2023-12-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0292664
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Peripheral Precocious Puberty of Ovarian Origin in a Series of 18 Girls: Exome Study Finds Variants in Genes Responsible for Hypogonadotropic Hypogonadism.

    Brauner, Raja / Bignon-Topalovic, Joelle / Bashamboo, Anu / McElreavey, Ken

    Frontiers in pediatrics

    2021  Volume 9, Page(s) 641397

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2021-05-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2711999-3
    ISSN 2296-2360
    ISSN 2296-2360
    DOI 10.3389/fped.2021.641397
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings.

    Globa, Evgenia / Zelinska, Natalia / Shcherbak, Yulia / Bignon-Topalovic, Joelle / Bashamboo, Anu / MсElreavey, Ken

    Frontiers in endocrinology

    2022  Volume 13, Page(s) 810782

    Abstract: Background: The clinical profile and genetics of individuals with Disorders/Differences of Sex Development (DSD) has not been reported in Ukraine.: Materials and methods: We established the Ukrainian DSD Register and identified 682 DSD patients. This ...

    Abstract Background: The clinical profile and genetics of individuals with Disorders/Differences of Sex Development (DSD) has not been reported in Ukraine.
    Materials and methods: We established the Ukrainian DSD Register and identified 682 DSD patients. This cohort includes, 357 patients (52.3% [303 patients with Turner syndrome)] with sex chromosome DSD, 119 (17.5%) with 46,XY DSD and 206 (30.2%) with 46,XX DSD. Patients with sex chromosome DSD and congenital adrenal hyperplasia (CAH, n=185) were excluded from further studies. Fluorescence
    Results: The majority of patients with 46,XY and 46,XX DSD (n=140), were raised as female (56.3% and 61.9% respectively). WES (n=79) identified pathogenic (P) or likely pathogenic (LP) variants in 43% of the cohort. P/LP variants were identified in the androgen receptor (
    Conclusions: WES is a powerful tool to identify novel causal variants in patients with DSD, including a significant minority that have an atypical clinical presentation. Our data suggest that heterozygous variants in the
    MeSH term(s) 46, XX Disorders of Sex Development ; Disorders of Sex Development/diagnosis ; Disorders of Sex Development/epidemiology ; Disorders of Sex Development/genetics ; Female ; Humans ; Hypogonadism ; In Situ Hybridization, Fluorescence ; Male ; Mutation ; Sex Chromosome Disorders of Sex Development ; Sexual Development
    Language English
    Publishing date 2022-03-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2022.810782
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pituitary stalk interruption syndrome is characterized by genetic heterogeneity.

    Brauner, Raja / Bignon-Topalovic, Joelle / Bashamboo, Anu / McElreavey, Ken

    PloS one

    2020  Volume 15, Issue 12, Page(s) e0242358

    Abstract: Pituitary stalk interruption syndrome is a rare disorder characterized by an absent or ectopic posterior pituitary, interrupted pituitary stalk and anterior pituitary hypoplasia, as well as in some cases, a range of heterogeneous somatic anomalies. A ... ...

    Abstract Pituitary stalk interruption syndrome is a rare disorder characterized by an absent or ectopic posterior pituitary, interrupted pituitary stalk and anterior pituitary hypoplasia, as well as in some cases, a range of heterogeneous somatic anomalies. A genetic cause is identified in only around 5% of all cases. Here, we define the genetic variants associated with PSIS followed by the same pediatric endocrinologist. Exome sequencing was performed in 52 (33 boys and 19 girls), including 2 familial cases single center pediatric cases, among them associated 36 (69.2%) had associated symptoms or syndromes. We identified rare and novel variants in genes (37 families with 39 individuals) known to be involved in one or more of the following-midline development and/or pituitary development or function (BMP4, CDON, GLI2, GLI3, HESX1, KIAA0556, LHX9, NKX2-1, PROP1, PTCH1, SHH, TBX19, TGIF1), syndromic and non-syndromic forms of hypogonadotropic hypogonadism (CCDC141, CHD7, FANCA, FANCC, FANCD2, FANCE, FANCG, IL17RD, KISS1R, NSMF, PMM2, SEMA3E, WDR11), syndromic forms of short stature (FGFR3, NBAS, PRMT7, RAF1, SLX4, SMARCA2, SOX11), cerebellum atrophy with optic anomalies (DNMT1, NBAS), axonal migration (ROBO1, SLIT2), and agenesis of the corpus callosum (ARID1B, CC2D2A, CEP120, CSPP1, DHCR7, INPP5E, VPS13B, ZNF423). Pituitary stalk interruption syndrome is characterized by a complex genetic heterogeneity, that reflects a complex phenotypic heterogeneity. Seizures, intellectual disability, micropenis or cryptorchidism, seen at presentation are usually considered as secondary to the pituitary deficiencies. However, this study shows that they are due to specific gene mutations. PSIS should therefore be considered as part of the phenotypic spectrum of other known genetic syndromes rather than as specific clinical entity.
    MeSH term(s) Child ; Child, Preschool ; Dwarfism/epidemiology ; Dwarfism/genetics ; Dwarfism/pathology ; Female ; Genetic Association Studies ; Genetic Heterogeneity ; Genetic Predisposition to Disease ; Humans ; Infant ; Infant, Newborn ; Male ; Mutation/genetics ; Nerve Tissue Proteins/genetics ; Pituitary Diseases/epidemiology ; Pituitary Diseases/genetics ; Pituitary Diseases/pathology ; Pituitary Gland/metabolism ; Pituitary Gland/pathology
    Chemical Substances Nerve Tissue Proteins
    Language English
    Publishing date 2020-12-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0242358
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A conserved NR5A1-responsive enhancer regulates SRY in testis-determination.

    Houzelstein, Denis / Eozenou, Caroline / Lagos, Carlos F / Elzaiat, Maëva / Bignon-Topalovic, Joelle / Gonzalez, Inma / Laville, Vincent / Schlick, Laurène / Wankanit, Somboon / Madon, Prochi / Kirtane, Jyotsna / Athalye, Arundhati / Buonocore, Federica / Bigou, Stéphanie / Conway, Gerard S / Bohl, Delphine / Achermann, John C / Bashamboo, Anu / McElreavey, Ken

    Nature communications

    2024  Volume 15, Issue 1, Page(s) 2796

    Abstract: The Y-linked SRY gene initiates mammalian testis-determination. However, how the expression of SRY is regulated remains elusive. Here, we demonstrate that a conserved steroidogenic factor-1 (SF-1)/NR5A1 binding enhancer is required for appropriate SRY ... ...

    Abstract The Y-linked SRY gene initiates mammalian testis-determination. However, how the expression of SRY is regulated remains elusive. Here, we demonstrate that a conserved steroidogenic factor-1 (SF-1)/NR5A1 binding enhancer is required for appropriate SRY expression to initiate testis-determination in humans. Comparative sequence analysis of SRY 5' regions in mammals identified an evolutionary conserved SF-1/NR5A1-binding motif within a 250 bp region of open chromatin located 5 kilobases upstream of the SRY transcription start site. Genomic analysis of 46,XY individuals with disrupted testis-determination, including a large multigenerational family, identified unique single-base substitutions of highly conserved residues within the SF-1/NR5A1-binding element. In silico modelling and in vitro assays demonstrate the enhancer properties of the NR5A1 motif. Deletion of this hemizygous element by genome-editing, in a novel in vitro cellular model recapitulating human Sertoli cell formation, resulted in a significant reduction in expression of SRY. Therefore, human NR5A1 acts as a regulatory switch between testis and ovary development by upregulating SRY expression, a role that may predate the eutherian radiation. We show that disruption of an enhancer can phenocopy variants in the coding regions of SRY that cause human testis dysgenesis. Since disease causing variants in enhancers are currently rare, the regulation of gene expression in testis-determination offers a paradigm to define enhancer activity in a key developmental process.
    MeSH term(s) Animals ; Female ; Humans ; Male ; Cell Line ; Gonadal Dysgenesis ; Mammals/genetics ; Regulatory Sequences, Nucleic Acid ; Sertoli Cells/metabolism ; Sex-Determining Region Y Protein/genetics ; Steroidogenic Factor 1/genetics ; Steroidogenic Factor 1/metabolism ; Testis/metabolism
    Chemical Substances NR5A1 protein, human ; Sex-Determining Region Y Protein ; Steroidogenic Factor 1 ; SRY protein, human ; HTRA2 protein, human (EC 3.4.21.108)
    Language English
    Publishing date 2024-03-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-024-47162-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Additional evidence for the role of chromosomal imbalances and SOX8, ZNRF3 and HHAT gene variants in early human testis development.

    Rjiba, Khouloud / Mougou-Zerelli, Soumaya / Hamida, Imen Hadj / Saad, Ghada / Khadija, Bochra / Jelloul, Afef / Slimani, Wafa / Hasni, Yosra / Dimassi, Sarra / Khelifa, Hela Ben / Sallem, Amira / Kammoun, Molka / Abdallah, Hamza Hadj / Gribaa, Moez / Bignon-Topalovic, Joelle / Chelly, Sami / Khairi, Hédi / Bibi, Mohamed / Kacem, Maha /
    Saad, Ali / Bashamboo, Anu / McElreavey, Kenneth

    Reproductive biology and endocrinology : RB&E

    2023  Volume 21, Issue 1, Page(s) 2

    Abstract: Background: Forty-six ,XY Differences/Disorders of Sex Development (DSD) are characterized by a broad phenotypic spectrum ranging from typical female to male with undervirilized external genitalia, or more rarely testicular regression with a typical ... ...

    Abstract Background: Forty-six ,XY Differences/Disorders of Sex Development (DSD) are characterized by a broad phenotypic spectrum ranging from typical female to male with undervirilized external genitalia, or more rarely testicular regression with a typical male phenotype. Despite progress in the genetic diagnosis of DSD, most 46,XY DSD cases remain idiopathic.
    Methods: To determine the genetic causes of 46,XY DSD, we studied 165 patients of Tunisian ancestry, who presented a wide range of DSD phenotypes. Karyotyping, candidate gene sequencing, and whole-exome sequencing (WES) were performed.
    Results: Cytogenetic abnormalities, including a high frequency of sex chromosomal anomalies (85.4%), explained the phenotype in 30.9% (51/165) of the cohort. Sanger sequencing of candidate genes identified a novel pathogenic variant in the SRY gene in a patient with 46,XY gonadal dysgenesis. An exome screen of a sub-group of 44 patients with 46,XY DSD revealed pathogenic or likely pathogenic variants in 38.6% (17/44) of patients.
    Conclusion: Rare or novel pathogenic variants were identified in the AR, SRD5A2, ZNRF3, SOX8, SOX9 and HHAT genes. Overall our data indicate a genetic diagnosis rate of 41.2% (68/165) in the group of 46,XY DSD.
    MeSH term(s) Female ; Humans ; Male ; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics ; Acyltransferases/genetics ; Gonadal Dysgenesis, 46,XY/genetics ; Membrane Proteins/genetics ; Mutation ; Phenotype ; Sex Differentiation ; Sexual Development/genetics ; SOXE Transcription Factors/genetics ; Testis/growth & development ; Ubiquitin-Protein Ligases/genetics
    Chemical Substances 3-Oxo-5-alpha-Steroid 4-Dehydrogenase (EC 1.3.99.5) ; Acyltransferases (EC 2.3.-) ; HHAT protein, human (EC 2.3.1.-) ; Membrane Proteins ; SOX8 protein, human ; SOXE Transcription Factors ; SRD5A2 protein, human (EC 1.3.99.5) ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; ZNRF3 protein, human (EC 2.3.2.27)
    Language English
    Publishing date 2023-01-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 2119215-7
    ISSN 1477-7827 ; 1477-7827
    ISSN (online) 1477-7827
    ISSN 1477-7827
    DOI 10.1186/s12958-022-01045-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Novel Genomic Variants, Atypical Phenotypes and Evidence of a Digenic/Oligogenic Contribution to Disorders/Differences of Sex Development in a Large North African Cohort.

    Zidoune, Housna / Ladjouze, Asmahane / Chellat-Rezgoune, Djalila / Boukri, Asma / Dib, Scheher Aman / Nouri, Nassim / Tebibel, Meryem / Sifi, Karima / Abadi, Noureddine / Satta, Dalila / Benelmadani, Yasmina / Bignon-Topalovic, Joelle / El-Zaiat-Munsch, Maeva / Bashamboo, Anu / McElreavey, Ken

    Frontiers in genetics

    2022  Volume 13, Page(s) 900574

    Abstract: In a majority of individuals with disorders/differences of sex development (DSD) a genetic etiology is often elusive. However, new genes causing DSD are routinely reported and using the unbiased genomic approaches, such as whole exome sequencing (WES) ... ...

    Abstract In a majority of individuals with disorders/differences of sex development (DSD) a genetic etiology is often elusive. However, new genes causing DSD are routinely reported and using the unbiased genomic approaches, such as whole exome sequencing (WES) should result in an increased diagnostic yield. Here, we performed WES on a large cohort of 125 individuals all of Algerian origin, who presented with a wide range of DSD phenotypes. The study excluded individuals with congenital adrenal hypoplasia (CAH) or chromosomal DSD. Parental consanguinity was reported in 36% of individuals. The genetic etiology was established in 49.6% (62/125) individuals of the total cohort, which includes 42.2% (35/83) of 46, XY non-syndromic DSD and 69.2% (27/39) of 46, XY syndromic DSD. No pathogenic variants were identified in the 46, XX DSD cases (0/3). Variants in the
    Language English
    Publishing date 2022-08-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2606823-0
    ISSN 1664-8021
    ISSN 1664-8021
    DOI 10.3389/fgene.2022.900574
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mutations in the Human ROBO1 Gene in Pituitary Stalk Interruption Syndrome.

    Bashamboo, Anu / Bignon-Topalovic, Joelle / Moussi, Nasser / McElreavey, Ken / Brauner, Raja

    The Journal of clinical endocrinology and metabolism

    2017  Volume 102, Issue 7, Page(s) 2401–2406

    Abstract: Context: Pituitary stalk interruption syndrome (PSIS) is characterized by a thin or absent pituitary stalk usually in association with an ectopic posterior pituitary and hypoplasia/aplasia of the anterior pituitary. Associated phenotypes include varied ... ...

    Abstract Context: Pituitary stalk interruption syndrome (PSIS) is characterized by a thin or absent pituitary stalk usually in association with an ectopic posterior pituitary and hypoplasia/aplasia of the anterior pituitary. Associated phenotypes include varied ocular anomalies, hypoglycemia, micropenis/cryptorchidism, growth failure, or combined pituitary hormone deficiencies. Although genetic causes have been identified, they explain only around 5% of PSIS cases.
    Objective: To identify genetic causes of PSIS by exome sequencing.
    Design: Exon enrichment was performed using the Agilent SureSelect Human All Exon V4. Paired-end sequencing was performed on the Illumina HiSeq2000 platform with an average sequencing coverage of ×50.
    Patients: Patients with unexplained PSIS were included in the study.
    Results: In five cases of unexplained PSIS including two familial cases, we identified a novel heterozygous frameshift and nonsense and missense mutations in the ROBO1 gene (p.Ala977Glnfs*40, two affected sibs; p.Tyr1114Ter, sporadic case, and p.Cys240Ser, affected child and paternal aunt) that controls embryonic axon guidance, and branching in the nervous system. Interestingly, four of the five cases of PSIS also presented with ocular anomalies, including hypermetropia with strabismus as well as ptosis.
    Conclusions: These data suggest that mutations in ROBO1 contribute to PSIS and associated ocular anomalies.
    MeSH term(s) Female ; Genetic Predisposition to Disease ; Humans ; Hypopituitarism/genetics ; Hypopituitarism/physiopathology ; Infant ; Infant, Newborn ; Male ; Mutation, Missense ; Nerve Tissue Proteins/genetics ; Pedigree ; Pituitary Gland/abnormalities ; Rare Diseases ; Receptors, Immunologic/genetics ; Sampling Studies ; Syndrome ; Roundabout Proteins
    Chemical Substances Nerve Tissue Proteins ; Receptors, Immunologic
    Language English
    Publishing date 2017-04-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3029-6
    ISSN 1945-7197 ; 0021-972X
    ISSN (online) 1945-7197
    ISSN 0021-972X
    DOI 10.1210/jc.2016-1095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Etiology of primary ovarian insufficiency in a series young girls presenting at a pediatric endocrinology center.

    Brauner, Raja / Pierrepont, Sophie / Bignon-Topalovic, Joelle / McElreavey, Ken / Bashamboo, Anu

    European journal of pediatrics

    2015  Volume 174, Issue 6, Page(s) 767–773

    Abstract: Unlabelled: The cause of the primary ovarian insufficiency (POI) remains unknown in the majority of cases. A retrospective study was carried out in 17 girls with POI and normal 46,XX karyotype evaluated before 20 years of age. The etiology of POI was ... ...

    Abstract Unlabelled: The cause of the primary ovarian insufficiency (POI) remains unknown in the majority of cases. A retrospective study was carried out in 17 girls with POI and normal 46,XX karyotype evaluated before 20 years of age. The etiology of POI was determined in eight girls (group 1) and remained idiopathic in nine girls (group 2). In group 1, five patients had a medical history: cerebellar ataxia due to congenital disorder of glycosylation (CDG) 1 in three cases, mitochondrial disease in one case, and autoimmune deficiencies in one case. The diagnosis of POI was made on pubertal delay or primary amenorrhea in these five patients, whilst the others presented with clitoral hypertrophy at birth or short stature and pubertal delay in two cases with NR5A1 mutation or with short stature and learning difficulties in one case with mitochondrial disease. In group 2, associated diseases were arthrogryposis malformative, gut, and bladder malformations and kidney failure or parieto-occipital tumor. The genes tested (NR5A1, BMP15, GDF9, and NOBOX) showed no mutation.
    Conclusions: The frequency of defined etiologies (47%) is high. This is probably because of the recruitment of the cases at the pediatric center, where other somatic anomalies can lead to the accurate determination of the etiology.
    MeSH term(s) Adolescent ; Amenorrhea/etiology ; Arthrogryposis/complications ; Autoimmune Diseases/complications ; Body Height ; Cerebellar Ataxia/etiology ; Child ; Clitoris/pathology ; Congenital Disorders of Glycosylation/complications ; Female ; Humans ; Hypertrophy ; Infant ; Karyotyping ; Learning Disorders/complications ; Mitochondrial Diseases/complications ; Mutation ; Primary Ovarian Insufficiency/diagnosis ; Primary Ovarian Insufficiency/etiology ; Puberty, Delayed ; Renal Insufficiency/complications ; Steroidogenic Factor 1/genetics
    Chemical Substances Steroidogenic Factor 1
    Language English
    Publishing date 2015-06
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 194196-3
    ISSN 1432-1076 ; 0340-6199 ; 0943-9676
    ISSN (online) 1432-1076
    ISSN 0340-6199 ; 0943-9676
    DOI 10.1007/s00431-014-2457-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The TALE homeodomain of PBX1 is involved in human primary testis-determination.

    Eozenou, Caroline / Bashamboo, Anu / Bignon-Topalovic, Joelle / Merel, Tiphanie / Zwermann, Oliver / Lourenco, Diana / Lottmann, Henri / Lichtenauer, Urs / Rojo, Sandra / Beuschlein, Felix / McElreavey, Ken / Brauner, Raja

    Human mutation

    2019  Volume 40, Issue 8, Page(s) 1071–1076

    Abstract: Human sex-determination is a poorly understood genetic process, where gonad development depends on a cell fate decision that occurs in a somatic cell to commit to Sertoli (male) or granulosa (female) cells. A lack of testis-determination in the human ... ...

    Abstract Human sex-determination is a poorly understood genetic process, where gonad development depends on a cell fate decision that occurs in a somatic cell to commit to Sertoli (male) or granulosa (female) cells. A lack of testis-determination in the human results in 46,XY gonadal dysgenesis. A minority of these cases is explained by mutations in genes known to be involved in sex-determination. Here, we identified a de novo missense mutation, p.Arg235Gln in the highly conserved TALE homeodomain of the transcription factor Pre-B-Cell Leukemia Transcription Factor 1 (PBX1) in a child with 46,XY gonadal dysgenesis and radiocubital synostosis. This mutation, within the nuclear localization signal of the protein, modifies the ability of the PBX1 protein to localize to the nucleus. The mutation abolishes the physical interaction of PBX1 with two proteins known to be involved in testis-determination, CBX2 and EMX2. These results provide a mechanism whereby this mutation results specifically in the absence of testis-determination.
    MeSH term(s) Female ; Gonadal Dysgenesis, 46,XY/genetics ; HEK293 Cells ; Homeodomain Proteins/metabolism ; Humans ; Models, Molecular ; Mutation, Missense ; Nuclear Localization Signals ; Polycomb Repressive Complex 1/metabolism ; Pre-B-Cell Leukemia Transcription Factor 1/chemistry ; Pre-B-Cell Leukemia Transcription Factor 1/genetics ; Pre-B-Cell Leukemia Transcription Factor 1/metabolism ; Sex Determination Processes ; Synostosis/genetics ; Transcription Factors/metabolism
    Chemical Substances CBX2 protein, human ; HOXB8 protein, human ; Homeodomain Proteins ; Nuclear Localization Signals ; Pre-B-Cell Leukemia Transcription Factor 1 ; Transcription Factors ; empty spiracles homeobox proteins ; PBX1 protein, human ; Polycomb Repressive Complex 1 (EC 2.3.2.27)
    Language English
    Publishing date 2019-05-21
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1126646-6
    ISSN 1098-1004 ; 1059-7794
    ISSN (online) 1098-1004
    ISSN 1059-7794
    DOI 10.1002/humu.23780
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top